Cite
HARVARD Citation
Piantoni, S. et al. (n.d.). A2.21 The increase of circulating CD4+ T-cells with effector phenotype in patients with systemic lupus erythematosus may be reverted after belimumab therapy. Annals of the rheumatic diseases. pp. A23-A24. [Online].